CBL & ASSOCIATES PROPERTIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CBL & ASSOCIATES PROPERTIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $578.37M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $515.56M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $535.29M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $563.01M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $108.85M | Feb 29, 2024 |
| FY2023 | Oct 31, 2021 | $468.03M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $575.86M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $190.04M | Mar 9, 2020 |
| FY2019 | Sep 30, 2019 | $187.25M | Mar 9, 2020 |
| FY2019 | Jun 30, 2019 | $193.38M | Mar 9, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.24M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $18.57M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $18.88M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $17.85M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $4.79M | Feb 29, 2024 |
| FY2023 | Oct 31, 2021 | $13.76M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $18.54M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $25.19M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $25.26M | Apr 8, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.97M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $58.97M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $6.55M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | ($93.48M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($151.55M) | Feb 29, 2024 |
| FY2023 | Oct 31, 2021 | ($470.63M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($295.08M) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $33.27M | Mar 9, 2020 |
| FY2019 | Sep 30, 2019 | ($78.89M) | Mar 9, 2020 |
| FY2019 | Jun 30, 2019 | ($24.18M) | Mar 9, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $83.00M | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $50.16M | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $22.31M | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $77.10M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $101.02M | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $36.73M | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $52.06M | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $63.83M | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $8.69M | Mar 1, 2017 |
| FY2016 | Sep 30, 2015 | $94.01M | Mar 1, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $249.68M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $202.22M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $183.52M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $208.23M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $57.05M | Feb 29, 2024 |
| FY2023 | Oct 31, 2021 | $107.06M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $133.37M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $273.41M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $377.24M | Apr 8, 2021 |
| FY2019 | Dec 31, 2017 | $430.40M | Mar 9, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.73B | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $2.75B | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $2.41B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $2.68B | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $2.95B | Feb 29, 2024 |
| FY2023 | Oct 31, 2021 | $2.96B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $4.44B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $4.62B | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $5.34B | Apr 8, 2021 |
| FY2018 | Dec 31, 2017 | $5.70B | Mar 1, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.36B | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $2.43B | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $2.08B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $2.31B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.54B | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $3.76B | Mar 9, 2020 |
| FY2019 | Dec 31, 2018 | $4.31B | Mar 9, 2020 |
| FY2012 | Dec 31, 2012 | $5.10B | Mar 1, 2013 |
| FY2012 | Dec 31, 2011 | $4.79B | Mar 1, 2013 |
| FY2011 | Dec 31, 2010 | $5.52B | Feb 29, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $374.94M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $323.55M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $339.32M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $370.54M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $396.20M | Mar 1, 2023 |
| FY2023 | Oct 31, 2021 | $547.45M | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $531.84M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $806.31M | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $964.14M | Mar 9, 2020 |
| FY2012 | Dec 31, 2012 | $1.33B | Mar 1, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($312.96M) | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | ($371.83M) | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | ($380.45M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | ($338.93M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($151.55M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($1.46B) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($1.16B) | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | ($1.01B) | Mar 9, 2020 |
| FY2012 | Dec 31, 2012 | ($453.56M) | Mar 1, 2013 |
| FY2012 | Dec 31, 2011 | ($399.58M) | Mar 1, 2013 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.29M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $40.79M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $34.19M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $44.72M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $169.55M | Feb 29, 2024 |
| FY2023 | Oct 31, 2021 | $260.21M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $61.78M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $32.82M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $25.14M | Apr 8, 2021 |
| FY2019 | Dec 31, 2017 | $32.63M | Mar 9, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.17B | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $2.21B | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $1.89B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $2.00B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.81B | Mar 1, 2023 |
| FY2023 | Oct 31, 2021 | $1.68B | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $1.18B | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $3.53B | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $4.04B | Mar 9, 2020 |
| FY2018 | Dec 31, 2017 | $4.23B | Mar 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | (3) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | (7) | Feb 29, 2024 |
| FY2023 | Oct 31, 2021 | (2) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Mar 1, 2023 |
| FY2018 | Dec 31, 2018 | 0 | Mar 1, 2019 |
| FY2018 | Sep 30, 2018 | 0 | Mar 1, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Mar 1, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | (3) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | (7) | Feb 29, 2024 |
| FY2023 | Oct 31, 2021 | (2) | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Mar 1, 2023 |
| FY2017 | Dec 31, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Mar 1, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 30.32M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | 30.71M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | 31.98M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 31.78M | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | 20.77M | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | 196.57M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 174.12M | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | 172.66M | Mar 9, 2020 |
| FY2014 | Dec 31, 2014 | 170.26M | Mar 2, 2015 |
| FY2014 | Dec 31, 2013 | 170.05M | Mar 2, 2015 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.10M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $50.36M | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $118.09M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $23.87M | Mar 3, 2025 |
| FY2021 | Dec 31, 2019 | $25.96M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $137.81M | Apr 8, 2021 |
| FY2019 | Dec 31, 2017 | $181.28M | Mar 9, 2020 |
| FY2012 | Dec 31, 2012 | $133.74M | Mar 1, 2013 |
| FY2012 | Dec 31, 2011 | $123.04M | Mar 1, 2013 |
| FY2010 | Dec 31, 2010 | $89.73M | Mar 3, 2011 |